Validation of FGFR screening by uromonitor and therascreen in FFPE tissue in bladder cancer in the context of the clinical-pathological real-world registry study “Bladder BRIDGister”Thorsten Ecke, Ralph M. Wirtz, F. Linden et al.|European Urology|2024Cited by 0